Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 47.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; croscarmellose sodium; methacrylic acid copolymer; povidone; macrogol 6000; microcrystalline cellulose; ethylcellulose; purified talc; silicified microcrystalline cellulose; sodium stearylfumarate; triethyl citrate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; sodium stearylfumarate; silicon dioxide; triethyl citrate; microcrystalline cellulose; purified talc; methacrylic acid copolymer; croscarmellose sodium; povidone; silicified microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: sodium stearylfumarate; silicon dioxide; ethylcellulose; triethyl citrate; methacrylic acid copolymer; povidone; purified talc; macrogol 6000; croscarmellose sodium; silicified microcrystalline cellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; triethyl citrate; povidone; silicified microcrystalline cellulose; microcrystalline cellulose; silicon dioxide; ethylcellulose; purified talc; macrogol 6000; croscarmellose sodium; sodium stearylfumarate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: silicified microcrystalline cellulose; triethyl citrate; purified talc; croscarmellose sodium; silicon dioxide; ethylcellulose; macrogol 6000; povidone; sodium stearylfumarate; methacrylic acid copolymer; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: triethyl citrate; macrogol 6000; croscarmellose sodium; povidone; sodium stearylfumarate; purified talc; silicon dioxide; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: purified talc; macrogol 6000; microcrystalline cellulose; povidone; silicon dioxide; triethyl citrate; sodium stearylfumarate; croscarmellose sodium; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 47.5 mg - tablet, modified release - excipient ingredients: triethyl citrate; croscarmellose sodium; microcrystalline cellulose; ethylcellulose; silicified microcrystalline cellulose; macrogol 6000; silicon dioxide; povidone; purified talc; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; silicified microcrystalline cellulose; triethyl citrate; macrogol 6000; silicon dioxide; croscarmellose sodium; purified talc; ethylcellulose; povidone; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: silicified microcrystalline cellulose; purified talc; macrogol 6000; methacrylic acid copolymer; microcrystalline cellulose; povidone; croscarmellose sodium; ethylcellulose; silicon dioxide; triethyl citrate; sodium stearylfumarate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.